StonvexLoading…
StonvexStonvexStonvexCore line items from AMSF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $84.81M | $80.09M | $317.25M | $235.66M | $153.69M |
Operating Income | Not available | $10.16M | $58.85M | $46.16M | $28.68M |
Net Income | Not available | $8.14M | $47.15M | $36.72M | $22.90M |
EPS (Diluted) | $0.53 | $0.43 | $2.47 | $1.92 | $1.20 |
Total Assets | Not available | $1.12B | $1.13B | $1.16B | $1.16B |
Total Liabilities | Not available | $876.36M | $878.95M | $890.17M | $889.54M |
Cash & Equivalents | Not available | $34.23M | $61.93M | $54.75M | $48.47M |
Free Cash Flow OCF − CapEx | Not available | $-2.72M | $8.92M | $-1.53M | $-11.32M |
Shares Outstanding | Not available | 18.70M | 18.79M | 18.99M | 19.02M |